Estate Counselors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-9,695
Closed -$1.52M – 142
2022
Q4
$1.52M Buy
9,695
+35
+0.4% +$5.03K 0.21% 63
2022
Q3
$1.19M Hold
9,660
– – 0.18% 64
2022
Q2
$1.28M Buy
+9,660
New +$1.32M 0.19% 58

Other funds holding DGX

Estate Counselors's DGX Position: Q1 2023 in Review

Estate Counselors sold out of Quest Diagnostics (DGX) in Q1 2023, closing a stake of 9,695 shares — an estimated $1.52M sold.

Estate Counselors first reported a position in DGX in Q2 2022 and held it in 3 quarters. The position peaked at $1.52M in Q4 2022. 834 funds tracked by Wall St. Rank hold DGX as of Q1 2023.

  • Estate Counselors reported no remaining Quest Diagnostics position as of Q1 2023 after selling out during the quarter.
  • Estate Counselors sold 9,695 Quest Diagnostics shares in Q1 2023, an estimated $1.52M.
  • Estate Counselors first reported a position in Quest Diagnostics in Q2 2022 and held it in 3 quarters.
  • Estate Counselors's Quest Diagnostics position peaked at $1.52M in Q4 2022.
  • 834 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2023.

Based on Estate Counselors's 13F filing for Q1 2023, filed 4 May 2023.